Literature DB >> 23354013

Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines.

Jinyu Xiang1, Wensheng Qiu, Xingang Wang, Fang Zhou, Zhen Wang, Shihai Liu, Lu Yue.   

Abstract

The ErbB-2 gene, whose overexpression is observed in many types of tumors including breast cancer, plays an important role in carcinoma formation. Dysregulation of the human transforming acidic coiled-coil 1 (TACC1) and ErbB-2 genes is thought to be important in the development and progression of breast cancer. However, a putative interaction between ErbB-2 and TACC1 remains undetermined in breast cancer. After infecting BT474 cells with lentiviral-mediated ErbB2-specific shRNA, we detected the expression of ErbB-2 and TACC1 by real-time PCR and western blotting. ErbB-2 mRNA expression was decreased in the Lenti-ShERBB2 infected cells, and western blotting indicated a concordant reduction in ErbB-2 protein. TACC1 expression at the mRNA and protein levels was significantly upregulated by ErbB-2 silencing in BT474 cells. CCK-8 assay indicated that the inhibition of ErbB-2 expression increased the sensitivity of BT474 cells to docetaxel treatment. These findings provide proof and the foundation for the molecular and biological relationships of ErbB-2 and TACC1 in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354013     DOI: 10.3892/or.2013.2253

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  3 in total

1.  Prognosis significance of HER2 status and TACC1 expression in patients with gastric carcinoma.

Authors:  Jing Lv; Ya-sai Yao; Fei Zhou; Li-kun Zhuang; Ru-yong Yao; Jun Liang; Wen-sheng Qiu; Lu Yue
Journal:  Med Oncol       Date:  2014-10-09       Impact factor: 3.064

2.  Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma.

Authors:  Pan Xu; Ran Zhao; Chen-Yang Zhang; Qian-Qian Zhang; Yong Wang; Jun Zhu; Wei-Wen Jiang
Journal:  Cell Death Discov       Date:  2021-12-11

3.  A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma.

Authors:  Yuting Dong; Xiaozhao Liu; Bijun Jiang; Siting Wei; Bangde Xiang; Ruichu Liao; Qiuyan Wang; Ximiao He
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.